223 related articles for article (PubMed ID: 11096775)
1. Guillain-Barré Syndrome.
van Der Meché FG ; van Doorn PA
Curr Treat Options Neurol; 2000 Nov; 2(6):507-516. PubMed ID: 11096775
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002063. PubMed ID: 25238327
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
van Doorn PA
Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2012 Jul; (7):CD002063. PubMed ID: 22786476
[TBL] [Abstract][Full Text] [Related]
5. IVIG treatment and prognosis in Guillain-Barré syndrome.
van Doorn PA; Kuitwaard K; Walgaard C; van Koningsveld R; Ruts L; Jacobs BC
J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S74-8. PubMed ID: 20396937
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study.
El-Bayoumi MA; El-Refaey AM; Abdelkader AM; El-Assmy MM; Alwakeel AA; El-Tahan HM
Crit Care; 2011 Jul; 15(4):R164. PubMed ID: 21745374
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Prognosis of Mechanically Ventilated Patients With Guillain-Barré Syndrome Is Worsened by Corticosteroids as an Add-On Therapy.
Wu X; Zhang B; Li C; Shen D; Liu K; Zhu J; Zhang HL
Medicine (Baltimore); 2015 Oct; 94(43):e1898. PubMed ID: 26512609
[TBL] [Abstract][Full Text] [Related]
8. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
[TBL] [Abstract][Full Text] [Related]
9. Treatment Efficacy of Plasmapheresis Versus Intravenous Immunoglobulin in Guillain-Barré Syndrome Management: A Systematic Review.
Savithri Nandeesha S; Kasagga A; Hawrami C; Ricci E; Hailu KT; Salib K; Butt S
Cureus; 2024 Mar; 16(3):e57066. PubMed ID: 38681292
[TBL] [Abstract][Full Text] [Related]
10. Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis.
Zaki HA; Iftikhar H; Najam M; Masood M; Al-Marri NDR; Elgassim MAM; Fayed M; Shaban EE
eNeurologicalSci; 2023 Jun; 31():100468. PubMed ID: 37288440
[TBL] [Abstract][Full Text] [Related]
11. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Hughes RA; Wijdicks EF; Barohn R; Benson E; Cornblath DR; Hahn AF; Meythaler JM; Miller RG; Sladky JT; Stevens JC;
Neurology; 2003 Sep; 61(6):736-40. PubMed ID: 14504313
[TBL] [Abstract][Full Text] [Related]
12. Intensive Care and Treatment of Severe Guillain-Barré Syndrome.
Shang P; Feng J; Wu W; Zhang HL
Front Pharmacol; 2021; 12():608130. PubMed ID: 33995011
[TBL] [Abstract][Full Text] [Related]
13. Initial Response and Outcome of Critically Ill Children With Guillain Barre' Syndrome.
Bazaraa HM; Rady HI; Mohamed SA; Rabie WA; ElAnwar NH
Front Pediatr; 2019; 7():378. PubMed ID: 31620410
[No Abstract] [Full Text] [Related]
14. Guillain-Barré syndrome: epidemiology, pathophysiology and management.
Kuwabara S
Drugs; 2004; 64(6):597-610. PubMed ID: 15018590
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and real-world outcomes of Guillain-Barré syndrome in the Philippines.
I Espiritu A; Separa KJNJ; Milla FJC; Adiao KJB; Leochico CFD; Jamora RDG
Neurol Res; 2021 Dec; 43(12):995-1004. PubMed ID: 34229572
[TBL] [Abstract][Full Text] [Related]
16. Current therapeutic options in severe Guillain-Barré syndrome.
Shahar E
Clin Neuropharmacol; 2006; 29(1):45-51. PubMed ID: 16518134
[TBL] [Abstract][Full Text] [Related]
17. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome. Clinical manifestations and directions for treatment.
Rees J
Drugs; 1995 Jun; 49(6):912-20. PubMed ID: 7641605
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin and Guillain-Barré syndrome.
Harel M; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):281-7. PubMed ID: 16391403
[TBL] [Abstract][Full Text] [Related]
20. The Guillain-Barré syndrome.
Fujimura H
Handb Clin Neurol; 2013; 115():383-402. PubMed ID: 23931791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
